-
EP2865381
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2865381
| EP2865381 - ITK inhibitors for treating blood cell malignancies [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.04.2018 Database last updated on 06.07.2024 | |
| Former | Request for examination was made Status updated on 01.01.2018 | Most recent event Tooltip | 13.04.2018 | Application deemed to be withdrawn | published on 16.05.2018 [2018/20] | Applicant(s) | For all designated states Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale, CA 94085 / US | [2015/18] | Inventor(s) | 01 /
Flynn, Gary A 9750 North Cliff View Place Tuscan, AZ 85737 / US | 02 /
Lee, Sandra Aeyoung Apartment C 15003 Dickens Street, Apt. C Sherman Oaks, CA 91403 / US | 03 /
Faris, Mary 2538 Almaden Court Los Angeles, CA 90077 / US | 04 /
Brandt, David William 4426 Daisy Court Moorpark, CA 93021 / US | 05 /
Chakravarty, Subrata 28233 Canterbury Court Valencia, CA 91354 / US | [2015/18] | Representative(s) | HGF 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | [N/P] |
| Former [2015/18] | Shah, Punita HGF Limited 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 14183381.4 | 18.05.2007 | [2015/18] | Priority number, date | US20060801074P | 18.05.2006 Original published format: US 801074 P | US20060869664P | 12.12.2006 Original published format: US 869664 P | [2015/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2865381 | Date: | 29.04.2015 | Language: | EN | [2015/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 31.03.2015 | Classification | IPC: | A61K31/445, A61K31/495, A61K31/4035, A61K31/472, A61K31/341, A61K31/5375, A61K31/496, A61K31/5377, A61K31/54, A61K31/551, A61P37/00, A61K31/33 | [2015/18] | CPC: |
A61K31/538 (EP,US);
A61K31/137 (EP,US);
A61K31/33 (EP,US);
A61K31/40 (EP,US);
A61K31/4035 (EP,US);
A61K31/445 (EP,US);
A61K31/47 (EP,US);
A61K31/495 (EP,US);
A61K31/5375 (EP,US);
A61K31/5377 (EP,US);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/02 (EP);
A61P7/04 (EP);
A61P7/06 (EP);
C07D207/08 (EP,US);
C07D207/14 (EP,US);
C07D209/44 (EP,US);
C07D211/10 (EP,US);
C07D211/26 (EP,US);
C07D211/30 (EP,US);
C07D217/04 (EP,US);
C07D265/36 (EP,US);
C07D295/108 (EP,US);
C07D295/185 (EP,US);
C07D295/192 (EP,US);
C07D295/215 (EP,US);
C07D307/52 (EP,US);
C07D307/80 (EP,US);
C07D317/54 (EP,US);
C07D319/18 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2015/18] | Title | German: | ITK-Hemmer zur Behandlung von bösartigen Blutzellenerkrankungen | [2015/18] | English: | ITK inhibitors for treating blood cell malignancies | [2015/18] | French: | Inhibiteurs de ITK pour le traitement des cancers des cellules sanguines | [2015/18] | Examination procedure | 03.09.2014 | Examination requested [2015/18] | 10.02.2016 | Amendment by applicant (claims and/or description) | 01.12.2017 | Application deemed to be withdrawn, date of legal effect [2018/20] | 02.01.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2018/20] | Parent application(s) Tooltip | EP07795056.6 / EP2027087 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 10.02.2016 | Request for further processing filed | 10.02.2016 | Full payment received (date of receipt of payment) Request granted | 22.02.2016 | Decision despatched | Fees paid | Renewal fee | 03.09.2014 | Renewal fee patent year 03 | 03.09.2014 | Renewal fee patent year 04 | 03.09.2014 | Renewal fee patent year 05 | 03.09.2014 | Renewal fee patent year 06 | 03.09.2014 | Renewal fee patent year 07 | 03.09.2014 | Renewal fee patent year 08 | 12.05.2015 | Renewal fee patent year 09 | 10.05.2016 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 31.05.2017 | 11 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2004067990 (BARRISH JOEL C [US], et al) [X] 1,2,6 * paragraphs [0005] , [0176] *; | [XY] - BROWN G R G R ET AL, "Naphthyl ketones: a new class of Janus kinase 3 inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, AMSTERDAM, NL, (20000301), vol. 10, no. 6, doi:10.1016/S0960-894X(00)00051-2, ISSN 0960-894X, pages 575 - 579, XP004190942 [X] 13-15 * tables 1,2 * [Y] 1-20 DOI: http://dx.doi.org/10.1016/S0960-894X(00)00051-2 | [X] - HUANG YUNSHENG ET AL, "Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents", DIE PHARMAZIE, GOVI VERLAG PHARMAZEUTISCHER VERLAG GMBH, ESCHBORN, DE, (19960101), vol. 51, no. 4, ISSN 0031-7144, pages 199 - 206, XP001526819 [X] 13-15 * table 1 * | [Y] - SUDBECK E A ET AL, "STRUCTURE-BASED DESIGN OF SPECIFIC INHIBITORS OF JANUS KINASE 3 AS APOPTOSIS-INDUCING ANTILEUKEMIC AGENTS", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (19990601), vol. 5, no. 6, ISSN 1078-0432, pages 1569 - 1582, XP000939043 [Y] 1-20 * the whole document * | [Y] - AMIN HESHAM M ET AL, "Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.", ONCOGENE 21 AUG 2003, (20030821), vol. 22, no. 35, ISSN 0950-9232, pages 5399 - 5407, XP002736144 [Y] 1-20 * the whole document * DOI: http://dx.doi.org/10.1038/sj.onc.1206849 | by applicant | US2005215582 | US2004077695 | US3845770 | US3916899 | US3536809 | US3598123 | US3944064 | US4008719 | - MAO ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 41435 - 41443 | - BROWN ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 18727 - 18732 | - SLICHENMEYER, W.J.; ELLIOTT, W.C.; FRY, D.W., SEMIN. ONEOL., (2001), vol. 28, pages 80 - 85 | - SHIMAMURA, T; JI, H.; MINAMI, Y.; THOMAS, R. K.; LOWELL, A.M.; SHA, K.; GREULICH, H.; GLATT, K.A.; MEYERSON, M.; SHAPIRO, I., CANCER RES., (2006), vol. 66, pages 6487 - 6491 | - EXP HEMATOL., (2006), vol. 34, pages 284 - 88 | - LEUK. LYMPHOMA., (2006), vol. 47, pages 521 - 29 | - LEUK. LYMPHOMA., (1992), vol. 7, pages 79 - 86 | - J. VIROL., (2006), vol. 79, pages 9449 - 57 | - NEOPLASIA, (2005), vol. 7, pages 984 - 91 | - OLIGONUCLEOTIDES, vol. 15, pages 85 - 93 | - TRANSFUS. APHER. SCI., (2005), vol. 32, pages 197 - 203 | - NATURE, (1991), vol. 17, pages 254 - 56 | - CELL. MOL. IMMUNOL., (2005), vol. 2, pages 461 - 65 | - PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 11823 - 28 | - ARTHRITIS RHEUM., (2004), vol. 50, pages 3250 - 59 | - CLIN. EXP. IMMUNOL., (1995), vol. 99, pages 294 - 302 | - J. CLIN. INVEST., (2006), vol. 116, pages 905 - 15 | - J. CLIN. INVEST., (2006), vol. 116, pages 961 - 973 | - ENDOCRINOL., (2006), vol. 147, pages 754 - 61 | - EXP MOL PATHOL., (2004), vol. 77, pages 161 - 67 | - J. RHEUMATOL. SUPPL., (1983), vol. 11, pages 114 - 17 | - RHEUMATOL., (2005), vol. 32, pages 1071 - 75 | - BRAIN PATHOL., (2002), vol. 12, pages 420 - 29 | - J. CLIN. INVEST., (2002), vol. 110, pages 955 - 63 | - VET. PATHOL., (1995), vol. 32, pages 337 - 45 | - IMMUNOL. INVEST., (2006), vol. 3, pages 47 - 61 | - ARCH. DERMATOL. RES., (2006), vol. 297, pages 333 - 44 | - J. EXP. MED., (2000), vol. 191, pages 899 - 906 | - J. VET. MED. SCI., (2006), vol. 68, pages 65 - 68 | - LIVER INT., (2005), vol. 25, pages 595 - 603 | - J. CLIN. INVEST., (1993), vol. 91, pages 1507 - 15 | - J. IMMUNOL., (2002), vol. 169, pages 4889 - 96 | - ISR. J. MED. SCI., (1979), vol. 15, pages 348 - 55 | - SURGERY, (2000), vol. 128, pages 999 - 1006 | - J. NEUROIMMUNOL., (1999), vol. 98, pages 130 - 35 | - AM. J. PATHOL., (1985), vol. 120, pages 323 - 25 | - BONE, (1997), vol. 20, pages 515 - 20 | - HAEMOPHILIA, (2005), vol. 11, pages 227 - 32 | - PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 233 - 36 | - PAIN, (2004), vol. 110, pages 56 - 63 | - ANN. NEUROL., (2001), vol. 49, pages 712 - 20 | - J. NEUROSCI. RES:, (1996), vol. 44, pages 58 - 65 | - EUR. J. IMMUNOL., (2002), vol. 32, pages 1147 - 56 | - HAEMATOLOGICA, (2003), vol. 88, pages 679 - 87 | - CURR. TOP. MICROBIOL. IMMUNOL., (2005), vol. 293, pages 153 - 77 | - J. IMMUNOL., (2005), vol. 175, pages 2475 - 83 | - INFLAMM. RES., (2004), vol. 53, pages 72 - 77 | - VET. PATHOL., (2006), vol. 43, pages 2 - 14 | - J. BIOL. CHEM., (2001), vol. 276, page 13821 |